DOI:
10.1055/s-00050590
Indian Journal of Radiology and Imaging
LinksClose Window
References
Meyer T, Fox R, Ma YT. et al.
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.
Lancet Gastroenterol Hepatol 2017;
2 (08) 565-575
We do not assume any responsibility for the contents of the web pages of other providers.